Nucleotides and Alzheimer’s disease: the latest study
Nucleotides and Alzheimer's disease: the latest study In 2019 Prosol announced the promising result of a first study on the role of dietary nucleotides (Ribodiet®) in Alzheimer disease. Last July a scientific study on the same topic was published on Biomedicine and Pharmacotherapy review; the study showed extremely interesting benefits of RIBODIET® in alleviating memory decline, neuroinflammation and oxidative stress. Alzheimer's disease is one of the most common form of dementia, characterized by the deposition of extracellular amyloid-β (Aβ) peptides in the brain. The neuronal death, that characterizes this neurodegenerative disorder, causes irreversible cognitive impairment and behavioral alteration. The option of natural-derived products and nutraceuticals is scientifically solid and to be considered for a future medical option in [...]
